Insider Selling: BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Director Sells 4,689 Shares of Stock
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report) Director Machelle Sanders sold 4,689 shares of the business’s stock in a transaction on Monday, June 17th. The stock was sold at an average price of $6.00, for a total value of $28,134.00. Following the completion of the transaction, the director now directly owns 27,742 shares in […]
More Stories
US Imposes Sanctions Targeting Iran’s Efforts to Obtain Air Defense Systems
By Timothy Frudd The Trump administration announced new sanctions on Wednesday targeting two individuals and one entity linked to Iran’s...
Blue Wave or Broken Count? The 2026 Midterms and the Case for Prosecuting Election Fraud
By Stephen Zogopoulos, USNN World News The 2026 midterms produced a decisive Democratic wave. Democrats flipped the Senate by a...
McDonald’s US Sales Slip as Lower Traffic Offsets Higher Customer Spending
By Bill Pan McDonald’s reported mixed third-quarter results as fewer visits to its U.S. restaurants outweighed higher spending per customer....
Dow Jones Rises More Than 1,000 Points as Wall Street Digests Midterm Results
By Andrew Moran U.S. stocks surged midweek as Wall Street digested the Democratic Party’s decisive midterm victory. The blue-chip Dow...
Navy Admiral Removed by Hegseth Flips South Carolina Seat Held by Nancy Mace
By Zachary Stieber A retired U.S. Navy admiral, removed by the Pentagon in 2025, has won a Republican-held House seat...
Data Centers Are Losing 38-1 at the Ballot Box With More to Count
By Jeremy Lott Data center developers are having a bad year at ballot boxes across America. On Nov. 3, many...